Trials / Completed
CompletedNCT05678595
The Effect of High-intensity Laser Therapy in Patients With Carpal Tunnel Syndrome.
The Effect of High-intensity Laser Therapy on Pain, Functional Status, Hand Grip Strength and Median Nerve Cross-sectional Area in Ultrasonography in Patients With Carpal Tunnel Syndrome.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Necmettin Erbakan University · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effects of high intensity laser therapy (HILT) on pain, functional status, hand grip strength and median nerve cross-sectional area in ultrasonography in patients with carpal tunnel syndrome.
Detailed description
Patients who are admitted and diagnosed with carpal tunnel syndrome based on anamnesis, physical examination and electromyography are included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | high-intensity laser therapy | HILT: A hot laser derived from a Nd: YAG laser has 12 W (watt) and 1064 nm characteristics. The device will administered to the hand wrist area in two steps in the HILT group: phase I and phase II. The application will made utilizing continuous circular movements in both phases I and II. The first five sessions consisted of a 100-second intermittent phase analgesic effect at 8 W and 8 J/cm2 for a total energy of 200 J. The following five sessions consisted of a continuous 11 minutes 6 second bio stimulating effect with a dosage of 3 W 80 J/cm2. Over the course of two weeks, ten treatment sessions of HILT will be given. |
| DEVICE | sham high-intensity laser therapy | HILT is administered as a placebo for two weeks, 5 sessions a week, for a total of 10 sessions. |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-06-23
- Completion
- 2023-06-23
- First posted
- 2023-01-10
- Last updated
- 2023-06-26
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05678595. Inclusion in this directory is not an endorsement.